Highlights
NASDAQ: XENT       Intersect Ent Inc
Last Price Today's Change   Day's Range   Trading Volume
20.885   +0.245 (1.19%)  20.56 - 21.075  127,831

Overview

 
Avg Volume (4 weeks):439,360
4 Weeks Range:16.19 - 22.95
4 Weeks Price Volatility (%):
69.45%
52 Weeks Range:14.61 - 35.87
52 Weeks Price Volatility (%):
29.52%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Intersect ENT Inc is a drug device company that develops products for patients with ear, nose, and throat conditions. The firm’s key commercial products are the Propel brand of steroid-releasing implants, which are used in patients undergoing surgery for chronic sinusitis. These implants are placed into the ethmoid sinuses after surgery and are designed to expand and hold open the surgically enlarged sinus while releasing an anti-inflammatory steroid. After roughly 30 days, the implant is fully absorbed into the body. Intersect ENT generates the vast majority of its revenue in the United States.

  Be the first to like this.
 


 

2977  2556  423  3021 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.909+0.099 
 CHK 0.696-0.006 
 AMD 38.319+0.799 
 CSCO 44.685-3.775 
 AABA 19.630.00 
 CPE 4.30-0.16 
 SNNA 0.30+0.14 
 NIO 1.735-0.165 
 NOK 3.356-0.114 
 AMRN 21.490.00 
Partners & Brokers